102 related articles for article (PubMed ID: 8618343)
1. Combination therapy of Pseudomonas aeruginosa pyelonephritis in neutropenic mice with human antilipopolysaccharide monoclonal antibody and cefsulodin.
Ishibashi K; Yamaguchi O; Shiraiwa Y; Ogihara M; Shigeta S
J Urol; 1996 Jun; 155(6):2094-7. PubMed ID: 8618343
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis.
Opal SM; Cross AS; Sadoff JC; Collins HH; Kelly NM; Victor GH; Palardy JE; Bodmer MW
J Clin Invest; 1991 Sep; 88(3):885-90. PubMed ID: 1885775
[TBL] [Abstract][Full Text] [Related]
3. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial properties of Pseudomonas aeruginosa immunotype 1 lipopolysaccharide-specific monoclonal antibody (MAb) in a murine thigh infection model: combined effects of MAb and ceftazidime.
Akiyama M; Oishi K; Tao M; Matsumoto K; Pollack M
Microbiol Immunol; 2000; 44(8):629-35. PubMed ID: 11021392
[TBL] [Abstract][Full Text] [Related]
5. Expression of intercellular adhesion molecule-1 in mice with Pseudomonas-induced pyelonephritis.
Yokoo A; Hirose T; Matsukawa M; Hotta H; Kunishima Y; Takahashi S
J Urol; 1998 Aug; 160(2):592-6. PubMed ID: 9679934
[TBL] [Abstract][Full Text] [Related]
6. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
Smith BR
Clin Pharm; 1984; 3(4):373-85. PubMed ID: 6380902
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia.
Oishi K; Sonoda F; Iwagaki A; Ponglertnapagorn P; Watanabe K; Nagatake T; Siadak A; Pollack M; Matsumoto K
Antimicrob Agents Chemother; 1993 Feb; 37(2):164-70. PubMed ID: 8383936
[TBL] [Abstract][Full Text] [Related]
9. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis.
Hemachandra S; Kamboj K; Copfer J; Pier G; Green LL; Schreiber JR
Infect Immun; 2001 Apr; 69(4):2223-9. PubMed ID: 11254577
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
Babalola CP; Nightingale CH; Nicolau DP
J Antimicrob Chemother; 2004 Jun; 53(6):1098-100. PubMed ID: 15128727
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide.
Bianco C; Bianco R; Tortora G; Damiano V; Guerrieri P; Montemaggi P; Mendelsohn J; De Placido S; Bianco AR; Ciardiello F
Clin Cancer Res; 2000 Nov; 6(11):4343-50. PubMed ID: 11106252
[TBL] [Abstract][Full Text] [Related]
12. [Study of the effect of combination therapy of human granulocyte-colony stimulating factor (G-CSF) and amikacin on experimental pyelonephritis induced by Pseudomonas aeruginosa in neutropenic mice].
Tanaka N; Kumamoto Y; Hirose T; Yokoo A
Kansenshogaku Zasshi; 1990 Aug; 64(8):994-1003. PubMed ID: 1698897
[TBL] [Abstract][Full Text] [Related]
13. Effect of adjunctive treatment with gamma interferon against Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
Babalola CP; Nightingale CH; Nicolau DP
Int J Antimicrob Agents; 2004 Sep; 24(3):219-25. PubMed ID: 15325424
[TBL] [Abstract][Full Text] [Related]
14. [Clinico-therapeutic and microbiological research on the preparation Monaspor in patients with active pyelonephritis].
Todorova L; Stefanov G; Dimitrov Ts; Anastasov G; Tishkov I
Vutr Boles; 1988; 27(1):68-72. PubMed ID: 3414087
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 deficiency in combination with macrophage depletion increases susceptibility to Pseudomonas aeruginosa bacteremia.
Horino T; Matsumoto T; Ishikawa H; Kimura S; Uramatsu M; Tanabe M; Tateda K; Miyazaki S; Aramaki Y; Iwakura Y; Yoshida M; Onodera S; Yamaguchi K
Microbiol Immunol; 2009 Sep; 53(9):502-11. PubMed ID: 19703244
[TBL] [Abstract][Full Text] [Related]
16. Contribution of free radicals to Pseudomonas aeruginosa induced acute pyelonephritis.
Mittal R; Sharma S; Chhibber S; Harjai K
Microb Pathog; 2008; 45(5-6):323-30. PubMed ID: 18771720
[TBL] [Abstract][Full Text] [Related]
17. Effects of the combination of lipopolysaccharide-specific monoclonal antibodies and sparfloxacin against Pseudomonas aeruginosa pneumonia in neutropenic mice.
Oishi K; Sonoda F; Iwagaki A; Kobayashi S; Nagatake T; Matsumoto K
Antimicrob Agents Chemother; 1992 Jul; 36(7):1352-7. PubMed ID: 1324643
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-9 amplifies the immune response to Pseudomonas aeruginosa corneal infection.
McClellan SA; Huang X; Barrett RP; Lighvani S; Zhang Y; Richiert D; Hazlett LD
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):256-64. PubMed ID: 16384971
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of anti-endotoxin monoclonal antibody E5 alone or in combination with ciprofloxacin in neutropenic rats with Pseudomonas sepsis.
Romulo RL; Palardy JE; Opal SM
J Infect Dis; 1993 Jan; 167(1):126-30. PubMed ID: 8418159
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of Pseudomonas infections in children with cefsulodin (author's transl)].
Rosenkranz A
Wien Med Wochenschr; 1981 Oct; 131(20):511-4. PubMed ID: 7314634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
